994 top medical experts on Primary Myelofibrosis across 45 countries and 35 U.S. states, including 941 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by cytokines arising from the abnormal clone.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Myeloproliferative Disorders (3,110).
  4. Clinical Trials ClinicalTrials.gov : at least 300 including 22 Active, 136 Completed, 75 Recruiting




    Computing Expert Listing ...